More Mental Health Visits Tied to Lower Rates of Youth Suicide
Youth suicide risk highest with epilepsy, depression, schizophrenia, substance use, bipolar disorder
Read MoreMay 1, 2020
Youth suicide risk highest with epilepsy, depression, schizophrenia, substance use, bipolar disorder
Read MoreMay 1, 2020
Survey reveals opportunities for more provider discussions, particularly for poor, uninsured women
Read MoreMay 1, 2020
In Australian cohort, reductions in MI, stroke, CVD death seen in those with type 2 diabetes
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Allergy for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Neurology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Nursing for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read MoreMay 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]
Read More